About this trial
This prospective, single-center, parallel-group, assessor-blinded randomized controlled trial will include 120 voluntary male participants who have had complaints of urinary frequency for at least 3 months and meet the inclusion criteria. Participants will be randomly allocated into two groups (Group 1: Bladder Training + Pelvic Floor Muscle Training; Group 2: Bladder Training Alone). Assessments will be repeated at baseline, at week 4, and at week 8. The primary outcome measure will be 3-day bladder diary data (24-hour voiding frequency); secondary outcomes will include the OAB-V8, ICIQ-OAB, and PGI-I scales, as well as transabdominal ultrasonographic measurements of bladder neck elevation (strength and endurance) and PVR.
Eligibility criteria
Qualifiers
Male sex
Age 18-65 years
Complaint of urinary frequency persisting for at least 3 months
On a 3-day bladder diary: ≥8 voids per 24 hours
Disqualifiers
Active urinary tract infection
Prostate cancer
Prostate surgery within the last 12 months
Parkinson's disease, Multiple sclerosis (MS), Stroke, Spinal cord injury
Trial design
Treatments tested in this trial
- Bladder training plus pelvic floor muscle training
- Bladder Training
Treatment groups
Locations
Sponsors and collaborators
Bingol University
Lead sponsor
Istanbul Rumeli University
Collaborator